| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.53B | 69.72B | 55.98B | 50.97B | 49.31B | 46.71B |
| Gross Profit | 57.20B | 63.18B | 53.62B | 49.77B | 48.89B | 46.42B |
| EBITDA | 10.48B | 18.44B | 14.13B | 11.12B | 10.56B | 10.09B |
| Net Income | 8.80B | 11.29B | 7.94B | 6.26B | 5.83B | 5.01B |
Balance Sheet | ||||||
| Total Assets | 3.02T | 2.94T | 2.98T | 2.93T | 2.88T | 2.86T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 201.70B | 349.39B | 439.56B | 510.74B | 590.65B |
| Total Debt | 98.58B | 96.26B | 99.84B | 94.55B | 161.03B | 222.29B |
| Total Liabilities | 2.87T | 2.77T | 2.83T | 2.78T | 2.72T | 2.70T |
| Stockholders Equity | 156.96B | 162.30B | 153.51B | 156.92B | 153.66B | 159.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.20B | 10.18B | -44.16B | -52.34B | 183.86B |
| Operating Cash Flow | 0.00 | 8.53B | 11.30B | -42.59B | -50.07B | 188.08B |
| Investing Cash Flow | 0.00 | -104.31B | -106.59B | -25.08B | -28.55B | -48.79B |
| Financing Cash Flow | 0.00 | -54.02B | -1.93B | -5.26B | -2.76B | -4.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥131.26B | 9.90 | ― | 2.71% | 21.01% | 42.25% | |
72 Outperform | ¥194.84B | 13.06 | ― | 2.23% | 31.23% | 66.11% | |
70 Outperform | ¥176.12B | 13.36 | 3.68% | 2.26% | 23.47% | 44.30% | |
69 Neutral | ¥135.55B | 62.06 | ― | 0.58% | 24.02% | 5.60% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥174.83B | 10.12 | ― | 2.29% | 9.41% | 45.91% | |
64 Neutral | ¥110.42B | 23.87 | ― | 2.46% | 16.88% | 59.34% |